INTRODUCTION
Recently, there has been a dramatic increase in the incidence of obesity in industrialized and newly developed countries (1). Obesity results from abnormal increases in white adipose tissue (WAT) mass leading to alterations in whole organism energy storage and utilization (2) (3) (4) . Increased adipose tissue mass can result from either an increase in individual adipocyte cell size (hypertrophy) or from an increase in total adipocyte number (hyperplasia). Alterations in whole organism lipid homeostasis leading to increased adipocyte tissue mass are highly correlated with the metabolic syndrome which is accompanied by its lethal sequelae of diabetes, hypertension and atherosclerosis (2) (3) (4) (5) . During the last decade, substantial progress has been made in understanding the biochemical events leading to adipocyte differentiation utilizing the hormone-induced 3T3-L1 cell model of adipocyte differentiation (6) (7) (8) (9) . Central to this understanding has been the detailed characterization of temporally coordinated changes in the expression of specific genes which collectively define the adipocyte phenotype.
Differentiation of adipocytes is accomplished by the programmed activation of transcriptional regulatory proteins which modulate the expression of mRNA and proteins which effectively reprogram 3T3-L1 cell lipid metabolism to that of a mature adipocyte.
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Phospholipases A 2 (PLA 2 s) catalyze the hydrolysis of the sn-2 fatty acid substituents from glycerophospholipid substrates to yield free fatty acid (e.g. arachidonic acid (AA)) and lysophospholipid (15) (16) (17) . Mammalian phospholipases A 2 have been categorized into several classes based on their requirement for calcium ion in in vitro activity assays (i.e., millimolar, nanomolar, or no calcium requirement) leading to their broad classification into three classes of enzymes: calcium independent phospholipase A 2 (iPLA 2 ), cytosolic phospholipase A 2 (cPLA 2 ) and secretory phospholipase A 2 (sPLA 2 ) (18). Prior studies have demonstrated that eicosanoids are potent modulators of adipocyte differentiation underscoring the roles of PGE 2 and PGI 2 in inducing transformation of progenitor cells into mature adipocytes (19, 20) . In contrast, PGF 2α inhibits hormone-induced differentiation of 3T3-L1 cells into mature adipocytes (21). In most mammalian cells, the rate-determining step in the production of biologically active eicosanoids is the release of arachidonic acid from the sn-2 position of glycerophospholipids. Despite the known importance of eicosanoids in modulating adipocyte differentiation, there is a paucity of information on the molecular identity of the specific types of intracellular phospholipases A 2 present in differentiating adipocytes, the alterations in protein mass and activity levels of the different intracellular phospholipase A 2 classes, and the importance of each specific type of phospholipase A 2 in adipocyte differentiation (14) . (MIX) and dexamethasone express the early transcription factors C/EBPβ and C/EBPδ which lead to their re-entry into the cell cycle (25, 26). C/EBPβ and C/EBPδ then activate the transcription of C/EBPα and PPARγ, which are believed to both be antimitotic and act synergistically to activate the expression of adipocyte specific genes leading to the differentiated adipocyte phenotype (27, 28) .
In this study, we demonstrate the dramatic up-regulation of both iPLA 2 β and iPLA 2 γ mRNA levels, protein content and enzymatic activities during hormone-induced differentiation of 3T3-L1 cells temporally coordinated with the down regulation of cPLA 2 α to near-background levels. Moreover, the essential roles of iPLA 2 β and iPLA 2 γ in adipocyte differentiation and their interplay with C/EBP and PPAR transcription factors have been identified by specific siRNA knockdown of either iPLA 2 β or iPLA 2 γ activity. The results demonstrate that down regulation of iPLA 2 β or iPLA 2 γ inhibits by guest on September 1, 2017 http://www.jbc.org/ Downloaded from 10 3T3-L1 cells were cultured to confluence in Dulbecco's modified Eagle's medium (DMEM) containing 10% calf serum (CS) by changing the medium every two days as previously described (30) . Two days after cell confluence, differentiation was initiated by adding differentiation medium 1 (0.5 mM MIX, 0.25 µM dexamethasone, 1 µg/mL insulin in DMEM containing 10% fetal bovine serum (FBS)). Two days later, MIX and dexamethasone were removed and insulin (1 µg/mL) was maintained for two more days.
Thereafter, cells were grown in DMEM containing 10% FBS in the absence of differentiating reagents by replacing the media every two days.
Reverse Transcription and Quantitative Polymerase Chain Reaction (PCR)
Total RNA was purified from 3T3-L1 cell pellets utilizing a RNeasy 
Protein Extraction and Western Blot
Protein from 3T3-L1 cells were extracted as described previously (31) . Briefly, the cell monolayer was washed with ice cold PBS and subsequently scraped into 1 mL ice cold lysis buffer (50 mM Tris.HCl, PH=7.4, 150 mM NaCl, 1 mM EDTA, 0.25% sodium deoxycholate, 1% Nonidet P-40, 0.1% SDS, 1 mM phenylmethylmethanesulfonyl fluoride, 2 µg/mL aprotinin and 1 µg/mL leupeptin). The solution was incubated on ice Reactions were quenched by addition of butanol (100 µL). 30 microliters of the organic phase of each sample were spotted on a Whatman silica plate which was developed with a nonpolar acidic mobile phase (100 mL of 70/30/1 petroleum ether/ ethyl ether/ acetic acid). Spots corresponding to fatty acids were scrapped into scintillation vials and radioactivity was quantified by scintillation spectrometry as described previously (32) .
BEL enantiomers were resolved by chiral HPLC as described previously (32) . For the inhibition assays of iPLA 2 by BEL, proteins were incubated with 10 µM (R)-BEL, (S)-13 BEL, racemic BEL or ethanol vehicle for 3 min at 22°C prior to the addition of radiolabelled substrate.
siRNA Construction and Transfection
The siRNAs directed against iPLA 2 β and iPLA 2 γ were constructed employing the 
Triacylglycerol Extraction and Electrospray Ionization Mass Spectrometry
After siRNA transfection, 3T3-L1 cells were grown to day 8 as described above. The cell monolayer was washed with ice-cold PBS and scraped into 1 mL 50 mM LiCl. The lipids were extracted by the method of in the presence of an internal standard (Tri17:0TAG, 200 nmol/mg protein). Mass spectral analysis of TAG was performed by electrospray ionization utilizing a Finnigan TSQ Quantum spectrometer (Finnigan MAT, San Jose, CA) as previously described (34) .
Protein Extraction from White Adipose Tissue of Zucker Rats
Female obese Zucker (fa/fa) rats and lean congenic controls (5-6 weeks old) were housed and maintained with a 12-hr light/12-hr dark photoperiod. Water and food were given ad libitum. Animals were sacrificed (asphyxiated by CO 2 ) and inguinal fat pads (WAT) were removed, rapidly frozen in liquid nitrogen and ground with a motor and pestle. To the tissue powder was added lysis buffer (50 mM Tris.HCl, PH=7.4, 150 mM NaCl, 1 mM EDTA, 0.25% sodium deoxycholate, 1% Nonidet P-40, 0.1% SDS, 1 mM phenylmethylmethanesulfonyl fluoride, 2 µg/mL aprotinin and 1 µg/mL leupeptin) and the resulting mixtures were homogenized with a Potter-Elvehjem apparatus. The homogenates were spun at 10,000g at 4°C in a tabletop centrifuge for 10 min and the supernatant was transferred to a new tube and stored at -70°C until used for Western blot analysis.
Miscellaneous
Protein concentration was determined utilizing a BCA protein assay kit (Pierce, Rockford, IL) with bovine serum albumin (BSA) as a standard. All data were normalized to protein content and are presented as the mean ± SEM. Statistically significant differences between mean values were determined using unpaired Student's t tests.
RESULTS

Alterations in the mRNA Levels of Intracellular Phopspholipases A 2 during Differentiation of 3T3-L1 Preadipocytes
Prior work has underscored the essential roles of eicosanoid metabolites and LPC derived LPA in adipocyte differentiation (19-22). Since these metabolites are all downstream products of PLA 2 catalyzed reactions, we sought to determine the specific types and amounts of PLA 2 mRNA, protein and activity corresponding to each of the previously characterized mammalian intracellular PLA 2 as a function of time after hormone-induced differentiation of 3T3-L1 preadipocytes. In resting cells, cPLA 2 α mRNA was prominent, with only minimal amounts of mRNA encoding iPLA 2 detectable.
However, after hormone-induced differentiation, the levels of cPLA 2 α mRNA decreased dramatically to near background levels ( Fig 1A) . Remarkably, the levels of iPLA 2 β and iPLA 2 γ mRNA increased 7.3±0.5 and 7.4±1.4 fold respectively (Fig 1B, 1C) .
Collectively, these results demonstrate the dramatic and temporally coordinated changes in the mRNA levels of each of the previously characterized mammalian intracellular PLA 2 during adipocyte differentiation.
Alterations of Intracellular Phospholipase A 2 Protein Mass and Activity during Differentiation of 3T3-L1 Preadipocytes
To further substantiate the functional importance of the observed alterations in mRNA levels, Western blot analysis was performed. Western analyses demonstrated a decrease in cPLA 2 α protein mass to near background levels (as predicted by the 16 decreased mass content of cPLA 2 α mRNA in the differentiating adipocyte) and the dramatic increases of both iPLA 2 β and iPLA 2 γ protein products (as predicted by increased mRNA levels encoding iPLA 2 β and iPLA 2 γ from quantitative PCR) (Fig 2) .
The temporal course of the increased amounts of iPLA 2 β and iPLA 2 γ protein and the decreased amount of cPLA 2 α protein were inversely regulated. Thus, the protein mass of each intracellular PLA 2 closely paralleled the intrinsic mRNA levels of each of three mammalian intracellular PLA 2 (i.e. cPLA 2 α, iPLA 2 β and iPLA 2 γ). Collectively, these results demonstrate the importance of transcriptional regulation in modulating reciprocal alterations in specific classes of intracellular PLA 2 during adipocyte differentiation.
To further investigate if alterations in the protein content of iPLA 2 β and iPLA 2 γ present during differentiation of 3T3-L1 cells were paralleled by changes in their activities, phospholipase A 2 activity assays were performed. During adipocyte differentiation iPLA 2 activity increased ≈4 fold ( Fig 3A) . As anticipated, the measured increase in iPLA 2 activity was inhibited by the mechanism-based inhibitor, racemic BEL ( Fig 3B) . Previously, we demonstrated that (S)-BEL was approximately one order of magnitude more selective for iPLA 2 β in comparison to iPLA 2 γ, while (R)-BEL was approximately an order of magnitude more selective for iPLA 2 γ (32). The measured iPLA 2 activity in 3T3-L1 adipocyte homogenate was inhibited to similar levels by either (S)-BEL or (R)-BEL ( Fig 3B) demonstrating that both iPLA 2 β and iPLA 2 γ contribute similarly to the total amounts of measured iPLA 2 activity in differentiated adipocytes. (Fig 6) . Interestingly, (S)-BEL is more potent than (R)-BEL in inhibiting adipogenesis (Fig 6) . This result suggests that S-BEL inhibits iPLA 2 β more potently than R-BEL inhibits iPLA 2 γ and agrees with our previous in vitro assay doseresponse profiles (32) . Collectively, these results demonstrate the importance of both iPLA 2 β and iPLA 2 γ in the adipocyte differentiation process by independent genetic and pharmacological approaches.
PPARγ and C/EBPα are believed to be prominent effectors of the genetic programs which induce the expression of adipocyte specific genes leading to the development of mature adipocytes (9, 13, 35, 36) . PPARγ and C/EBPα) (Fig 7B) . Moreover, the transient expression of liver-enriched inhibitory protein (LIP) isoform of C/EBPβ, which arises from utilization of an alternative translation initiation site and is believed to be a dominant-negative regulator of C/EBP family members (39), was also not affected by siRNAs directed toward iPLA 2 β or iPLA 2 γ (Fig 7B) . The lower expression levels of LAP isoform of C/EBPβ on day 4 after silencing iPLA 2 β or iPLA 2 γ suggest that both iPLA 2 β and iPLA 2 γ play roles in degradation or turnover of LAP (Fig 7B) . Since the expression levels of C/EBPβ decreased by over 80% on day 4 (compared to day 2), this result suggests that the temporal progression of this large decrease may be marginally delayed. Previous work has demonstrated the requirement of C/EBPβ for mitotic clonal expansion during adipogenesis (25, 26) . The present results demonstrate that hormone-induced early stage mitotic clonal expansion was not affected by pretreatment with siRNA directed against iPLA 2 β or iPLA 2 γ (Fig 8) . Collectively, these results suggest that the down-regulation of 
Alterations of iPLA 2 β and iPLA 2 γ Expression Level in the Zucker Obese Rat
Dysregulation of a gene in the obese state provides important clues to the functional relevance of the gene in the obese state and the mechanism contributing to obesity in that model. Up-regulation of iPLA 2 β and iPLA 2 γ and the requirement of these two phospholipase proteins for adipogenesis in hormone-induced differentiation of 3T3-L1 cells suggest that they may be involved in the development of obesity. Accordingly, we investigated the modulation of iPLA 2 β and iPLA 2 γ expression levels in Zucker (fa/fa) obese rats. 5-week-old female lean and homozygeous obese rats were fed ad libitum.
Animals were sacrificed and inguinal fat pads (WAT) were removed for protein extraction. Protein extracts were analyzed for alterations in the expression of iPLA 2 β and iPLA 2 γ by immunoblot analysis. Western blots of iPLA 2 β showed the dramatic upregulation of the 65 kDa and 40 kDa iPLA 2 β protein products in obese animals relative to their congenic lean controls in white adipose tissue (Fig 10A) . The identities of the 65 kDa and 40 kDa bands were substantiated by blocking nonspecific immunoreactivity by preincubating the antibody solution with excess amounts of antigen peptide (Fig 10A) .
Similarly, the expression level of the 63 kDa isoform of iPLA 2 γ was also dramatically increased in the white adipose tissue of Zucker obese rats in comparison to that of lean control (Fig 10B) . Interestingly, the level of the 48 kDa iPLA 2 γ proteolytic product was not altered. The identities of both 63 kDa and 48 kDa bands were also substantiated by blocking the antibody in the presence of excess amounts of peptide antigen (Fig 10B) .
Collectively, these results demonstrate the dramatic changes in iPLA 2 β and iPLA 2 γ regulation in a commonly utilized genetic model of diabetes and obesity.
DISCUSSION
The present study provides multiple independent lines of evidence that iPLA 2 
